Pfizer’s alopecia tablet approved by FDA in adults and teens, winning broader market than Lilly's Olumiant
The FDA has given a thumbs-up to the first treatment option for adolescents with alopecia areata, an autoimmune disease that leads to hair loss. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
